FDA Safety Communication: FDA Provides Interim Results of Duodenoscope Reprocessing Studies Conducted in Real-World Settings

Stephen B. Hanauer, MD, FACG Chair, ACG FDA Related Matters Committee On December 10, the U.S. Food & Drug Administration (FDA) released interim results from post-market surveillance studies on contamination rates with duodenoscopes after ...

FDA’s Safety Communication on Supplemental Measures to Enhance Duodenoscope Reprocessing

Stephen B. Hanauer, MD, FACG The FDA today announced supplemental measures to enhance duodenoscope reprocessing, including all Endoscopic Retrograde Cholangiopancreatography (ERCP) endoscopes. The College recognizes that this important infection ...